Switching from scanned to real-time CGM for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether switching from a FreeStyle Libre 2 (which you scan to check sugar) to a Dexcom G7 (which sends sugar readings automatically to your phone) can improve blood sugar control in adults with type 2 diabetes who use insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have type 2 diabetes for at least 1 year
- You've been using insulin for at least 6 months
- You currently use a FreeStyle Libre 2 (scanned) CGM and want to switch to a Dexcom G7 (real-time) CGM
- Your most recent HbA1c (blood sugar average over 3 months) is 7.5% or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study tests a new way to diagnose diabetes in older adults by using a continuous glucose monitor (CGM) — a small sensor worn on the arm — to get a more accurate picture of blood sugar than the standard A1c test alone. If you qualify, you'll wear the sensor for about 48 days, and the results may help your doctor know whether you truly have diabetes.
This study looks at using a continuous glucose monitor (a small sensor that tracks blood sugar all day) in people with type 2 diabetes who are not taking insulin. It aims to see if using the monitor helps improve blood sugar control.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.